SEC Tracker
Get the app

Recursion Pharmaceuticals RXRX

Najat Khan, insider filing for RXRX

Form
4
Filed
Importance
Routine

Not explained yet; the original is on EDGAR.

View on EDGAR

Open in the app

Get an email when Recursion Pharmaceuticals files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Same SIC code (2836) and public float over $2B, nearest public float first, as each company reports it on its annual report cover.

  1. Vericel VCEL public float $2.1B, Jun 30, 2025
  2. Kymera Therapeutics KYMR public float $2.3B, Dec 31, 2025
  3. Twist Bioscience TWST public float $2.3B, Mar 31, 2025, over 18 months old
  4. Scholar Rock Holding SRRK public float $2.6B, Jun 30, 2025
  5. Arcellx ACLX public float $3.2B, Jun 30, 2025

Data on this page was fetched . The filing on SEC.gov is the record.